Ra Capital Management, L.P. Bolt Biotherapeutics, Inc. Transaction History

Ra Capital Management, L.P.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$1.48 - $2.61 $123,270 - $217,389	83,291 Added 18.5%	533,432 $789,000
Q2 2022 Aug 15, 2022	BUY	$1.41 - $2.91 $634,698 - $1.31 Million	450,141 New	450,141 $918,000
Q1 2022 May 16, 2022	SELL	$2.74 - $4.82 $6.52 Million - $11.5 Million	-2,378,325 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$25.86 - $39.93 $61.5 Million - $95 Million	2,378,325 New	2,378,325 $78.3 Million

19.1M

Ticker BOLT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 37,641,500
Market Cap $19.2M
Description
Bolt Biotherapeutics, Inc., a clinical-stage biotechnology company, engages in the development of immuno-oncology agents to target tumor cells for elimination by the immune system. The company is developing BDC-1001, a human epidermal growth factor receptor 2 (HER2), which is in Phase I/II clinical trial for the treatment of patients with HER2-e...

Get notified when there are updates to the investment portfolio of Ra Capital Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Ra Capital Management, L.P. with notifications on news.